FDA Approves Eli Lilly's Alzheimer's Treatment Donanemab
FDA Approves Donanemab for Early Alzheimer’s Treatment.
Disclaimer: The information provided in this article is based on current knowledge and scientific understanding as of the date of publication. This content does not constitute medical advice and should not be used as a substitute for professional consultation with a healthcare provider.
Real-time information is available daily at …